医学
内科学
曲妥珠单抗
人口
胃肠病学
临床终点
肺癌
临床研究阶段
肿瘤科
癌症
临床试验
外科
乳腺癌
环境卫生
作者
Kōichi Goto,Yasushi Goto,Toshio Kubo,Kiichiro Ninomiya,Sang‐We Kim,David Planchard,Myung‐Ju Ahn,Egbert F. Smit,Adrianus J. de Langen,M. Pérol,Elvire Pons‐Tostivint,Silvia Novello,Hidetoshi Hayashi,Junichi Shimizu,Dong‐Wan Kim,Chih‐Hsi S. Kuo,James Chih‐Hsin Yang,Kaline Pereira,Fu-Chih Cheng,Ayumi Taguchi
摘要
Trastuzumab deruxtecan (T-DXd) 5.4 and 6.4 mg/kg showed robust antitumor activity in multiple cancer indications; however, T-DXd 5.4 mg/kg has not been evaluated in patients with previously treated human epidermal growth factor receptor 2-mutant (
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
哆啦的空间站
馆长
浮游
Criminology34
冬雪丶消融
GingerF
机灵柚子
哈基米德
YifanWang
leaolf
PAGAX_Father
GPTea
核桃
tuanheqi
从容芮
MchemG
哭泣的雪巧
xiaoyinni
Hilda007
yuki
情怀
DORAAA
完美世界
柴桑青木
彩虹儿
Aphcity
changfox
Zoom
皖公网安备34019202002308
